Treatment-Resistant Depression & the Neurobiology of Suicide
Date and Time
Sponsor(s): NIMH Division of Intramural Research Programs (IRP)
Join experts from the National Institute of Mental Health (NIMH) for a workshop on treatment-resistant depression and the neurobiology of suicide.
An Update on the Research and Management of Treatment-Resistant Depression
Speaker: Carlos A. Zarate, M.D.
- To understand the causes of treatment-resistant depression.
- To become familiar with research on treatment-resistant depression, particularly with ketamine and other glutamatergic modulators.
- To understand research on biomarkers of treatment response.
An Update on the Neurobiology of Suicide
Speaker: Elizabeth Ballard, Ph.D.
- Provide an overview of recent research on the neurobiology and epidemiology of suicide
- Present research on potential interventions with rapid impact on suicidal thoughts
Major Depression: A Brain and Systemic Illness
Speaker: Bashkim Kadriu, M.D.
- To understand the effect of depression in the brain and systemic illness.
- To understand the effect of depression in increasing risk on medical systemic illnesses.
- How current therapeutics affect medical illnesses.
- To Understand the effects of novel fast-acting antidepressants in treatment of medical systemic illnesses.
Use of Non-invasive Brain Stimulation to Remediate Depression
Speaker: Bruce Luber, Ph.D.
- To present our ongoing research using both non-convulsive and convulsive brain stimulation to modulate targeted brain networks involved with treatment-resistant depression.
Ketamine: A Novel Agent for Treatment-Resistant Depression
Speaker: Elia Acevedo, MD
- Provide an overview of ketamine research and its promising results as a fast-acting antidepressant
- To understand potential safety concerns and side effects associated with the use of ketamine for the treatment of depression.
More Information: https://videocast.nih.gov/summary.asp?live=28960&bhcp=1